Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Lasa Supergenerics Limited
LASA | NSE
27.08
INR-0.57
-2.06%
LASA | NSE
About Lasa Supergenerics Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
18/10/2024
Close
27.08
Open
27.25
High
27.98
Low
26.50
Lasa Supergenerics Limited engages in the research manufacture and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole toldimphos sodium cyromazine albendazole riclabendazole rafoxanide ornidazole ricobendazole oxfendazole closantel base closantel sodium nitroxynil halquinol and oxyclozanide as well as 26-diiodo-4-nitrophenol; and other API products such as anthelmintics. The company also provides animal feed ingredients including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai India.
View LessLASA | NSE
Risk
50.8
Sharpe
-0.08
Luna's Score
52/100
Recommendation
Hold
Luna says (LASA | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
48.6%1 month
50.8%3 months
63.8%6 months
53.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.43
Debt to equity
0.23
Debt to assets
0.15
Ent. to EBITDA
-13.02
Ent. to rev.
1.52
PEG
-
Other Fundamentals
EBITDA
-9.17M
MarketCap
1.37B
MarketCap(USD)
16.54M
Div. yield
-
Op. margin
-3.23
Erngs. growth
224.80
Rev. growth
0.90
Ret. on equity
-20.22
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
4.53
Range1M
5.83
Range3M
10.96
Volumes: Market Activity
Rel. volume
0.68
Price X volume
915.79K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -13.02 | 24.85 | Cheaper |
| Ent. to Revenue | 1.52 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 1.43 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 63.85 | 42.17 | Riskier |
| Debt to Equity | 0.23 | 0.35 | Cheaper |
| Debt to Assets | 0.15 | 0.17 | Par |
| Market Cap | 1.37B | 290.82B | Emerging |
